SPECTRAL AI INC. - CLASS A COMMON STOCK

Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System

12 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem

07 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Appoints Peter M. Carlson as CEO

29 Feb 2024 17:30:52 By Nasdaq GlobeNewswire

Spectral AI to Participate in Upcoming Investor Conferences

28 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024

22 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors

12 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

06 Feb 2024 09:00:31 By Nasdaq GlobeNewswire

Spectral AI Announces Publication of Letter to Shareholders

05 Feb 2024 09:00:00 By Nasdaq GlobeNewswire

Spectral Submits Application for UKCA Mark Classification

29 Jan 2024 09:33:05 By Nasdaq GlobeNewswire

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

11 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO

19 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

Spectral AI to Participate in Benchmark’s 12th Annual Discovery One-on-One Conference

30 Nov 2023 16:10:10 By Nasdaq GlobeNewswire

Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

27 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Announces 2023 Third Quarter Financial Results

13 Nov 2023 18:11:38 By Nasdaq GlobeNewswire

Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call

01 Nov 2023 08:00:55 By Nasdaq GlobeNewswire

Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEA

24 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Provides 2023-2024 Annual Revenue Guidance

23 Oct 2023 08:00:59 By Nasdaq GlobeNewswire

Spectral AI’s DeepView SnapShot® Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification

19 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

Spectral AI Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer (DFU) Study

16 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

Spectral AI CEO, Wensheng Fan, to Participate in AI Healthcare Panel at Accelerate Health Conference

05 Oct 2023 08:00:00 By Nasdaq GlobeNewswire